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Abstract The bone marrow harbors a population of
mesenchymal stem cells (MSCs) that possess the potential
to differentiate into bone, cartilage, and fat, and along
other tissue pathways. To date, MSCs from various species
have been studied. Despite the bovine experimental model
being widely used in experiments in vivo and in vitro, only
a limited amount of information regarding bovine MSCs is
available. The aim of this study was to isolate and induce
the multilineage mesenchymal differentiation of bovine
MSCs, thereby initiating further research on these cells.
Bovine MSCs were isolated from eight calves, and
osteogenic, chondrogenic, and adipogenic differentiation
was induced by using a combination of previously
reported protocols for other species. The level of differ-
entiation was evaluated by histological examination and
by analyzing the expression of tissue-specific genes by a
quantitative “real time” reverse transcription/polymerase
chain reaction technique. Following osteoinduction, the
isolated fibroblast-like cells transformed into cuboidal
cells and formed alkaline-phosphatase-positive colonies;
during differentiation, these colonies transformed into
mineralized nodules. In addition, osteogenesis was
followed by osteocalcin and collagen type I mRNA
expression. Chondrogenesis was confirmed by the de-
monstration of collagen type II, aggrecan, and sox9
mRNA expression in the cells stimulated by transforming
growth factor β1 in monolayer culture. After being
cultured in an adipogenesis-inducing medium, the MSCs
responded by the accumulation of lipid vacuoles and the
expression of adipocyte-specific genes. We have therefore
demonstrated that cells harvested from bovine bone
marrow are capable of in vitro extensive multiplication
and multilineage differentiation, making them a relevant
and invaluable model in the field of stem cell research.
Keywords Mesenchymal stem cells . Multilineage
differentiation . Bovine experimental model
Introduction
Bone marrow mesenchymal stem cells (MSC) have
potential to differentiate into cells with mesenchymal,
mesodermal, neuroectodermal or endodermal characteris-
tics (Jiang et al. 2002a, 2002b). In addition, the pluripotent
character of adult stem cells present in the muscle, brain,
adipose tissue, and dermis of the skin has also been
confirmed (Jiang et al. 2002a, 2002b; Zuk et al. 2002;
Toma et al. 2001). Pluripotent cells are an attractive
promising source in the field of tissue regeneration and
engineering, particularly because the use of human
embryonic stem cells is limited by ethical considerations
(Frankel 2000).
MSCs can be directly isolated from bone marrow
aspirates (1) based on their ability to adhere to plastic
when plated in a monolayer culture or (2) with micro-
magnetic beads by using specific antibodies for stem cells
(STRO1, CD105; positive selection) or for hematopoetic
cells (CD45, GlyA; negative selection; Gronthos and
Simmons1995; Majumdar et al. 2000; Reyes et al. 2001).
Under appropriate cell culture conditions and stimulation
by certain exogenous or endogenous (gene transfer)
bioactive factors, MSCs can differentiate into various
cell lineages, such as osteocytes, adipocytes, chondro-
cytes, myocytes, hepatocytes, astrocytes, or neurons
(Wang et al. 2003; Lagasse et al. 2000; Woodbury et al.
2000).
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MSCs transplanted into bone and cartilage defects are
able to differentiate into osteoblast and cartilage and can
repair damaged tissue by newly synthesized bone or
hyaline cartilage, respectively (Bruder et al. 1998;
Wakitani et al. 1994, 2002; Liu et al. 2002). Similarly,
when injected into cardiac muscle, MSCs acquire the
phenotype of cardiac myoblasts (Orlic et al. 2001). These
characteristics indicate that MSCs can be used as powerful
tools in reconstructive medicine.
The apparent plasticity of adult stem cells in vivo may
be attributed to de-differentiation, trans-differentiation, or
cell–cell fusion (Wagers et al. 2004). Whereas most
studies have not sufficiently fulfilled the criteria proposed
as the requisite proof of de-differentiation and trans-
differentiation (Wagers et al. 2002; Goodell 2003; Rodic et
al. 2004), cell fusion has recently been well presented as a
mechanism involved in the contribution of transplanted
bone marrow cells to liver hepatocytes, cardiac myocytes,
and Purkinje neurons (Alvarez-Dolado et al. 2003;
Vassilopoulos et al. 2003; Weimann et al. 2003). However,
differentiation by cell fusion has been reported to occur
only in some types of cells, whereas in other cell types,
cell-fusion-independent differentiation has been reported,
making all of the presently proposed mechanisms
debatable (Ianus et al. 2003; Wurmser et al. 2004).
Ever since Friedenstein et al. (1976) first observed that
bone marrow contains fibroblastic cells that are capable of
differentiating into bone and adipose tissue, numerous
studies have advanced our understanding of the pheno-
type, physiology, differentiation potential, and possible
clinical application of these cells. MSCs used in these
studies have been sourced from various species, including
humans and small experimental animals such as rat,
mouse, and rabbit, and large animals such as dog, cat, pig,
and horse (Kadiyala et al. 1997; Martin et al. 2002; Ringe
et al. 2002; Fortier et al. 1998; Pittenger et al. 1999).
However, limited information regarding bovine MSCs is
available, despite the wide application of the bovine
experimental model in both in vivo and in vitro
experiments, particularly in research on chondrocyte
metabolism and cartilage resurfacing.
In the present study, we have isolated bovine MSCs and
induced chondrogenesis, adipogenesis, and osteogenesis,
thereby establishing a new experimental animal model for
this type of research. The use of a large animal
experimental model in this type of research provides
numerous advantages, particularly prior to the transfer of
regeneration technology to human medicine, because large
animals are biomechanically more relevant to humans than
small experimental animals (Aerssens et al. 1998; Liu et
al. 2002; Bosnakovski et al. 2004; Kon et al. 2000).
Materials and methods
Harvesting and isolation of bovine MSC
Bone marrow was aspirated from eight calves (2–6 months
old). The marrow was drawn into syringes containing
heparin (1,000 units) and kept on ice until later use.
Bovine MSC were isolated by previously described
methods (Worster et al. 2000a, 2000b; Mastrogiacomo et
al. 2001; Holzer et al. 2002; Bosnakovski et al. 2004).
Briefly, the bone marrow sample was washed twice with
phosphate-buffered saline (PBS) and twice with Dulbec-
co’s Modified Eagle Medium (DMEM; GIBCO BRL,
Grand Islands, N.Y., USA). Following the determination
of cell viability and number, nucleated cells (5×104/cm2)
were plated in T-75 culture flasks in control medium
consisting of DMEM (low glucose) with 100 U/ml
penicillin G, 100 μg/ml streptomycin, 0.25 μg/ml ampho-
tericin B, 2.4 mg/ml HEPES, 3.7 mg/ml NaHCO3, and
10% fetal bovine serum (FBS; lot no. 5300C, ICN,
Biomedicals, Ohio, USA). The cells were incubated at
37°C in a humidified atmosphere containing 5% CO2.
After being cultured for 4 days, non-adherent cells were
removed by changing the culture medium. Following the
initial 4 days, which were required for the cells to attach to
the flask, the medium was changed every 2–3 days. On
day 12 or 13, the cells were detached by using 0.25%
trypsin in 0.1% EDTA and either used in experiments or
stored by deep-freezing in 10% dimethylsulfoxide until
further use.
Cell proliferation assay
Proliferation of the cells was assayed by the Hoechst
33258 fluorescent dye technique (Kim et al. 1988).
Briefly, the cells, which were cultured in monolayers,
were detached by trypsin, collected in a 1.5-ml centrifuge
tube, and digested overnight at 60°C with papain (125 μg/
ml; Sigma, St Louis, Mo., USA) in PBS containing 5 mM
EDTA, 5 mM L-cysteine hydrochloride. The amount of
DNA was measured in triplicate by using Hoechst 33258
dye (Sigma) in a spectrofluorometer (FP777; Jasco,
Tokyo, Japan) with excitation (365 nm) and emission
(440 nm).
Osteogenic differentiation
Osteogenic differentiation was induced in the cells from
the primary culture and from the first passage by using
combinations of previously published protocols in order to
enhance the expression of an osteogenic lineage (Jaiswal
et al. 1997; Pittenger et al. 1999). In the primary culture
(Fig. 1), osteogenesis was initiated from the first day of
culturing by using osteogenic medium (Dex), viz., control
medium containing 100 nM dexamethasone, 10 mM
sodium β-glycerophosphate, 0.05 mM ascorbic acid (all
from Sigma). Bone marrow nucleated cells (5×104/cm2)
were plated in T-60 culture dishes. The dishes were
divided into two groups based on the culture medium; in
one group (Cont), the cells were cultured in control
medium alone, whereas in the other group, they were
cultured in the osteogenic medium (Dex). The cells were
cultured for 24 days with the medium being changed every
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3 days. On day 24, the cells from half of the dishes in each
group were exposed to 10 nM 1,25-dihydroxyvitamin D3
(vitamin D; Biomol Research Laboratory, Plymouth
Meeting, Pa., USA) added to control or osteogenic
medium for three more days, thereby forming the
following four experimental groups: control, control +
vitamin D, Dex, and Dex + vitamin D (Fig. 1).
To analyze osteogenic gene expression during differen-
tiation, MSCs (3×103/cm2) from the first passage were
plated in 6-well plates and cultured until subconfluence
(80%). Subsequently, three experimental groups, namely,
the control, Dex, and control + vitamin D groups, were
formed based on the culture medium used. Differentiation
was closely followed during the 9 days of treatment.
During the experiment, the level of osteogenic differ-
entiation was analyzed by the visualization of alkaline
phosphatase (ALP) activity and by the demonstration of
mineralized materials in the cell culture by using von
Kossa staining. Total RNAwas harvested on day 27 (at the
completion of the differentiation protocol) from the cells in
the primary culture and on days 3, 6, and 9 from the cells
treated in the first passage.
Chondrogenic differentiation in monolayer culture
MSCs were plated with a density of 2–5×103 cells/cm2 in
6-well plates and cultured until the cells reached
subconfluence. To induce chondrogenic differentiation,
the cells were treated with 1 ng/ml or 5 ng/ml transforming
growth factor beta 1 (TGF-β1; R&D Systems, Minnea-
polis, Minn., USA) in plain medium (Worster et al. 2000a,
2000b). In the control group, the cells were cultured in
control medium alone. The level of differentiation was
determined by analyzing the expression of cartilage-
specific genes by quantitative “real time” reverse tran-
scription/polymerase chain reaction (qRT-PCR) on days 3
and 6 of treatment.
To analyze the effect of various concentrations of
TGF-β1 (0, 1, 5, and 10 ng/ml) on bovine MSC
proliferation, the cells were cultured under the culture
conditions previously described for cell differentiation.
Proliferation was analyzed by the measurement of DNA
content during the 9 days of treatment.
Adipogenic differentiation
MSC from the first or second passages were plated at a
density of 2–5×103 cells/cm2 in 6-well plates and cultured
in control medium until the cell culture reached conflu-
ence. At this point, adipogenic stimulation was initiated by
culturing the cells in adipogenesis-inducing medium
containing DMEM (high glucose, 4.5 g/l), 1 μM dexa-
methasone, 0.5 mM indomethacin, 10 μg/ml insulin, 100
mM 3-isobutyl-1-methylxantine (all from Sigma), 10%
FBS for 3 days, and for 3 more days in adipogenesis-
maintenance medium containing DMEM (high glucose,
4.5 g/l), 10 μg/ml insulin, and 10% FBS. This stimulation
was twice repeated (total 18 days treatment; Janderova et
al. 2003). The cells in the control group were cultured in
control medium (high glucose). The level of differentiation
was closely followed by means of a phase-contrast
microscope and by histological examination. The expres-
sion of the adipogenic-specific genes, peroxisome pro-
liferator-activated receptor gamma 2 (PPAR-γ2) and
adipocyte fatty-acid-binding protein (aP2), was analyzed
on day 18 of differentiation.
Histological staining
The deposition of minerals in the cultures was demon-
strated by von Kossa staining. Cell cultures in each
experimental group were rinsed twice in PBS, fixed with
3.7% paraformaldehyde for 15 min, and rinsed three times
in distilled water. The cells were stained with 2% silver
nitrate in a dark environment for 10 min followed by
washes and exposure to light for 10 min.
In glutaraldehyde-fixed cells, ALP activity was visua-
lized by the azo-dye method by using naphthol AS-BI
phosphate and Fast blue BB salt as the substrate.
Accumulation of the lipid vacuoles was visualized by
Oil red O staining as follows. In brief, 10% formalin-fixed
cells were stained with 0.2% Oil red O for 2 h, thoroughly
rinsed in water, and counterstained with hematoxylin.
Measurement of mRNA level by qRT-PCR method
Total RNA was isolated by using Trizol (Invitrogen, Life
Technologies, Carlsbad, Calif., USA) in accordance with
the manufacturer’s instruction. After the samples were
treated with DNase to remove possible contamination by
genomic DNA, first-strand complementary DNA (cDNA)
was synthesized from 2 μg total RNA by using M-MLV
reverse transcriptase (Invitrogen) with oligo (dT)20 as a
primer in 20 μl reaction mixture. The amount of cDNA
was measured by the qPCR method by using the Smart
Cycler System (Cepheid, Calif., USA). PCR was carried
Fig. 1 Scheme of the osteogenic differentiation protocol in primary
culture. Cells in the control group (Cont) were cultured in control
medium; cells in the osteogenic group (Dex) were cultured in
osteogenic medium; cells in the Cont + Vit D and Dex + Vit D
groups were cultured in control and osteogenic medium, respec-
tively, supplemented with 10 nM 1,25-dihydroxyvitamin D3 (Vit D)
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out in a 25-μl final volume containing PCR buffer, 3 mM
MgCl2, 0.3 mM dNTP mixture, 0.3 μM each of the
relevant bovine-specific primer (Table 1), and Taq poly-
merase (1.25 units/tube; Takara Biomedicals, Otsu, Japan).
Forty-five cycles of thermal cycling were carried out at
95°C for 5 s, 55°C-60°C for 15 s, and 75°C for 15 s. The
amount of PCR product was estimated by measurement of
the intensity of fluorescence of SYBR Green I interacting
with the PCR product. The mRNA expression level of
target genes was normalized by dividing with the mRNA
level of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; osteogenesis and chondrogenesis) or β-actin
(adipogenesis). The quality of the PCR products was
checked by melting curve analysis and electrophoresis. In
addition, the identity of each PCR product was confirmed
by sequence analysis (ABI-PRISM 310 Genetic Analyzer;
PE Biosystems, Foster City, Calif., USA).
Statistical analyses
Data from a minimum of four independent experiments
were evaluated and expressed as mean ± SD. An unpaired
Student’s t test was used to test significance between the
two groups. The results were considered significantly
different at P<0.05.
Results
Cell culture
MSCs were isolated from bovine bone marrow based on
their characteristic property of attaching to plastic culture
flasks. The isolated cells that were cultured in monolayer
had a bipolar to polygonal fibroblast-like shape (Fig. 2).
During monolayer culturing (up to 6 passages) by standard
cell culture techniques, no remarkable loss was noted in
the cell proliferation potential (data not shown).
Osteogenic differentiation
Bovine MSCs grown in the primary culture with the
osteogenic medium (Dex) formed colonies, and their
cellular morphology changed from a fibroblastic shape to a
cuboidal form. The cell colonies were found to be ALP-
positive on days 12 and 27 of differentiation (Fig. 3a, b).
During the culture period, the colonies transformed into
mineralized nodules that were demonstrated by von Kossa
staining (Fig. 3c). On the other hand, the cells cultured in
control medium did not form colonies and retained their
fibroblastic shape. A 3-day additional treatment with
vitamin D in cell culture had no notable influence on cell
shape, ALP activity, or mineralized nodule formation.
After 27 days of osteogenesis, significant differences in
the expression of collagen type I mRNA were found
between the two groups (P<0.01); the expression was 2.8
times higher in the group cultured with dexamethasone Ta
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than in the control group (Fig. 4a). Gene expression of
osteocalcin, a typical marker of the osteoblastic pheno-
type, was only detected in the cells treated with vitamin D
(Fig. 4b). In contrast, it was not detected in the cells
treated with dexamethasone alone or cultured in control
medium for 27 days.
The first-passage cells that were cultured in the
osteogenic medium also transformed into cells with a
cuboidal-shape; however, colonies and mineralized nod-
ules were not formed. These cells showed 6.9 and 5.5
times higher expression level of collagen type I mRNA on
days 3 and 9, respectively, when compared with the
controls (P<0.01). The expression level of collagen type I
mRNA in osteogenic medium increased with time and was
1.5 times higher on day 9 than on day 3 of differentiation
(Fig. 5a). The cells in the groups treated with vitamin D
showed an increased expression level of collagen type I
mRNA when compared with the control group; however,
this was negligible when compared with the groups treated
with dexamethasone. Osteocalcin was detected after 6
days of stimulation of cells with vitamin D, and its
expression had significantly (P<0.01) increased (by 6.3
times) after 3 days of additional treatment (Fig. 5b).
Chondrogenic differentiation
Bovine MSCs cultured in monolayer and treated with
TGF-β1 exhibited a more rounded shape than the cells
from the control group. By day 3, cultures treated with
TGF-β1 showed a prominent increase in cellular density
Fig. 2 Morphology of bovine MSCs cultured in monolayer; phase-
contrast microscopy. The cells exhibited a fibroblast-like shape. Bar
100 μm
Fig. 3 Osteogenic differentiation demonstrated by histological
methods. MSCs cultured in osteogenic medium formed colonies
that were found to be positive for alkaline phosphatase (ALP)
staining (a). During culture, the colonies transformed into nodules
that were found to be positive for ALP (b) and von Kossa staining
(c)
Fig. 4 a Quantitative analysis of collagen type I gene expression by
MSCs in primary culture on day 27 in the control (Control), control
+ vitamin D (Con + Vit D), Dex (Dex), and Dex + vitamin D (Dex +
Vit D) groups. The expression level was normalized with the level of
GAPDH mRNA. In the control group, expression of collagen type I
mRNA was represented as 1. Data of four independent experiments
were evaluated and expressed as mean ± SD. *P<0.05 when
compared with the control group. b Electrophoresis of the PCR
products from RT-PCR analysis of osteocalcin (OST) and GAPDH
mRNA (GAPDH) expression in cells from primary culture (day 27)
in the control (lane 1), control + vitamin D (lane 2), Dex (lane 3),
and Dex + vitamin D (lane 4) groups. No osteocalcin was detected
in cells untreated with vitamin D for 3 days and in the final stage of
osteogenic differentiation.
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with multilayering; this was more pronounced on day 6.
The effect on cell morphology was correlated with the
concentration of TGF-β1 in the medium. The most
pronounced response was observed in cultures treated
with >5 ng/ml TGF-β1. The MSCs started detaching on
the second day of treatment with 10 ng/ml TGF-β1 (data
not shown). The detachment was more prominent during
the culture period; therefore, this group was excluded from
further studies. The expression of chondrocyte-specific
genes that occurred following TGF-β1 treatment was
found to be dose-dependent and time-dependent. Treat-
ment with 5 ng/ml TGF-β1 increased type II collagen
expression by 4.7 and 14.2 times on days 3 and 6,
respectively, when compared with the cells cultured in the
control groups (P<0.05 and P<0.0001; Fig. 6a). On day 6,
the expression of aggrecan in the cells treated with 5 ng/ml
TGF-β1 was twice that in the control cells (P<0.01; Fig.
6b). Sox9, an early marker of chondrogenic differentia-
tion, was detected as early as the third day of treatment
with 5 ng/ml TGF-β1. On day 6, expression increased 5.6
times compared with that on day 3 (P<0.05; Fig. 6c).
The effects of TGF-β1 on cell proliferation were also
analyzed. After 3 days of treatment with 1 ng/ml or 5 ng/
ml TGF-β1, cell proliferation significantly (P<0.01)
increased 1.9 and 2.3 times, respectively, when compared
with the controls (Table 2). During the 9 days of treatment
with TGF β1, the rate of increased proliferation persisted
at approximately the same level.
Adipogenic differentiation
Adipogenic differentiation was revealed by changes
observed in the cell morphology that followed the
formation of lipid vacuoles and by the expression of
adipose-specific genes. Following the first induction
Fig. 5 a Quantitative analysis of collagen type I mRNA in the cells
from the first passage in the control (Control), Dex (Dex), and
control + vitamin D (Vit D) groups. b Osteocalcin gene expression
by MSC from the first passage treated with 10 ng/ml vitamin D for 9
days. The expression level was normalized for the level of GAPDH
mRNA. The expression of collagen type I mRNA in the control
group on day 3 and that of osteocalcin in the treatment group on day
9 are represented as 1. Values are expressed as mean ± SD. *P<0.05
when compared with the control on the same day (a) and on day 3
(b)
Fig. 6 Quantitative analysis of chondrogenic gene expression by
MSCs treated with TGF-β1. The expression level was normalized
for the level of GAPDH mRNA. The expression of collagen type II
(a) and aggrecan (b) in the cells in the control group on day 3 are
represented as 1. The expression of sox9 (c) in the cells in the group
treated with 5 ng/ml TGF-β1 on day 6 is represented as 1. Data of
four independent experiments were evaluated and expressed as
mean ± SD. *P<0.05 when compared with the control (0 ng/ml
TGF-β1) on the same day
Table 2 Influence of TGF-β1 on the proliferation of cells during
culture in monolayer for 9 days. The treatment of cell cultures with
various concentrations of TGF-β1 was started at the stage of
subconfluence (day 0). DNA content on day 0 is represented as 1,
and the data is presented as n-fold differences (±SD).
TGF β1 Day 0 Day 3 Day 6 Day 9
0 ng/ml 1±0.16 1.14±0.23 1.46±0.26 1.96±0.24
1 ng/ml 1±0.16 2.21±0.30* 3.40±0.42* 3.56±0.47*
5 ng/ml 1±0.16 2.58±0.27** 4.20±0.46** 4.24±0.48**
*P<0.01, **P<0.001 when compared with the control group (0 ng/
ml TGF-β1) on the same day
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treatment, small vacuoles were observed in the oval-
transformed cells by phase-contrast microscopy. Oil red O
staining confirmed that these were lipid droplets (Fig. 7b).
The number of vacuoles and their size increased during the
culture period, reaching a maximum following the third
induction treatment (Fig. 7c, d). After 18 days of
differentiation, 50%–90% of the cells contained lipid
vacuoles of varying sizes. This estimation was carried out
by counting the cells that had acquired an adipocytic
phenotype in a minimum of five microscopic fields. On
the other hand, cells in the control groups maintained their
fibroblastic shape with a sporadic incidence of cells
containing small vacuoles stained by Oil red O. On day 18
of differentiation, the expression of adipocyte-specific
genes was analyzed by qRT-PCR. Expression of PPAR-γ2
was observed only in the adipogenesis-induced cells (Fig.
8a). The expression of aP2 was significantly (P<0.001)
increased, viz., 8.4-fold (Fig. 8b), when compared with the
control group.
Discussion
The capability of fibroblast-like cells, isolated from bovine
bone marrow, to undergo osteogenic, chondrogenic, and
adipogenic differentiation under adequate culture condi-
tions has been demonstrated in the present study. These
fibroblast-like cells cells, referred to as MSCs, have been
found to be pluripotent, as are their rodent, feline, porcine,
and human counterparts.
Fig. 7 Adipogenic differentia-
tion of MSCs; Oil red O staining
of the cells in the control group
on day 6 (a) and in the adipo-
genesis-induced group (b) after
the first adipogenic treatment (3
days culturing in adipogenesis-
inducing medium followed by 3
days culturing in the adipogen-
esis-maintaining medium).
Small lipid vacuoles were de-
tected in the cells in the treated
group (white arrows). Morphol-
ogy of the cells by phase-con-
trast microscopy (c) and Oil red
O staining (d) after three cycles
of adipogenesis induction (total
18 days) showing the increase in
size of the lipid vacuoles, and
the typical morphology of adi-
pocytes. Bar 100 μm
Fig. 8 Gene expression prior to adipogenic differentiation. a
Electrophoresis of the PCR products from RT-PCR analysis of
PPAR-γ2 and β-actin mRNA expression in the cell culture for 18
days in the control (lane 1) and adipogenesis-induced (lane 2)
groups. PPAR-γ2 was detected only in the treated cells. b
Quantitative analysis of aP2 mRNA expression in the adipogene-
sis-induced cells and in the control cells on day 18. The expression
level was normalized for the level of β-actin mRNA. The expression
of aP2 in the control group is represented as 1. Data have been
expressed as mean ± SD. *P<0.05
249
The techniques used for the isolation and differentiation
MSCs were a combination of those previously used in
other species together with minor modifications aimed at
achieving a better expression of lineage markers (Ringe et
al. 2002; Martin et al. 2002; Heng et al. 2004).
Osteogenesis was confirmed by the presence of the ALP
enzyme, a tissue non-specific (bone/liver/kidney/cartilage/
fat) but well-known early osteo-differentiation marker, by
the expression of osteocalcin and collagen type I mRNA,
and by the mineralization of the matrix. Currently, a
definitive marker for cells of the osteogenic lineage is
unknown; however, the three criteria mentioned above are
widely accepted as being characteristic of osteoblasts
(Andrades et al. 1999; Mizuno et al. 2000; Walsh et al.
2003; De Jong et al. 2004; Chen 2004). On exposure to
osteoinductive medium, bovine MSCs, like those from
other species, transformed from a fibroblastic to a cuboidal
shape, thereby exhibiting osteoblastic morphology. In
primary culture, changes in the cell morphology were
followed by cell growth into colonies and the formation of
ALP-positive mineralized nodules, a characteristic of
osteogenesis in rat and human MSCs (Mizuno et al.
2000; Bruder et al. 1997) but not in feline or ovine MSCs
(Martin et al. 2002; Kon et al. 2000). Bovine MSCs
expressed osteocalcin mRNA in response to vitamin D but
not to dexamethasone treatment. The same behavior was
reported in human MSCs, which when treated with
dexamethasone, expressed considerably less osteocalcin
than did cells that were not cultured in osteoinductive
medium prior to treatment with vitamin D. This could be
attributable to the glucocorticoid-induced reduction of
vitamin D receptors in osteoblastic cells, leading to
decreased osteocalcin expression during vitamin D treat-
ment (Jaiswal et al. 1997). The expression of collagen type
I mRNA increased in the cells treated with osteoinductive
medium, a result indicating the occurrence of osteodiffer-
entiation in the bovine MSCs.
During osteogenesis in the first passage, the bovine
MSCs lost the ability to form mineralized nodules;
however, the potential to express osteocalcin and collagen
type I mRNA was maintained. This modification in the
manner of osteogenic phenotype expression does not
necessarily imply that the cells lose their potential to
differentiate. Satomura et al. (2000) have shown that the
formation of mineralized nodules in vitro does not predict
actual osteogenic capability in vivo because clonal lines of
certain murine cells do not form nodules in culture but are
able to form bone when transplanted into immunocom-
promised mice. However, the loss in their potential for
differentiation during culturing could be attributed to
several factors, including species character, cell isolation,
and culture techniques, and conditions in the culture
medium (Kadiyala et al. 1997; Sekiya et al. 2002;
Digirolamo et al. 1999).
Close cell-to-cell contact and certain chondrogenic
bioactive factors are widely accepted as being two main
principles involved in enhancing chondrogenic differenti-
ation. The best method to obtain strong cell-to-cell
interaction is to culture MSCs in a pellet or micromass
culture system (Johnstone et al. 1998; Jones et al. 2002).
The bioactive factors that stimulate chondrogenesis
include TGF-β1, bone morphogenic protein, fibroblast
growth factor, and insulin-like growth factor (Mastrogia-
como et al. 2001). TGF-β1 acts via high-affinity interac-
tion with a heteromeric receptor complex comprising two
structurally-related serine-threonine kinases, the type I and
II receptors, and transduces its signals through Smad
proteins intracellularly (Miyazono 2000). In addition to
the pellet and micromass culture systems, Worster et al.
(2000a) have induced chondrogenesis in equine MSCs in
monolayer culture by using TGF-β1. We have reported the
spontaneous chondrogenic differentiation of bovine
MSCs, independent of exogenous bioactive substances,
in a pellet culture system and thereby have confirmed the
importance of culture conditions prior to chondrogenesis
(Bosnakovski et al. 2004). In the present study, the
potential of bovine MSCs to undergo chondrogenesis has
been analyzed after treatment with TGF-β1 in monolayer
culture. The chondrogenic differentiation of MSCs in
monolayer culture apears to be dose-dependent and time-
dependent in relation to TGF-β1, despite its suppressive
effect on chondrogenesis in pellet culture (Bosnakovski et
al. 2004). In our system, TGF-β1 induces increased
collagen type II expression (14.2 times), which clearly
demonstrates the chondrogenic effect of this factor. Cells
cultured with no treatment with any bioactive substance do
not express sox9, an early transcription factor of chon-
drogenesis. However, it is detectable after treatment with
TGF-β1. Sox9 has been shown to regulate the rate of
chondrocyte differentiation by controlling the expression
of a series of chondrocyte-specific genes, including those
for aggrecan and collagens type II, IX, and XI (De
Crombrugghe 2000; Tchetina et al. 2003). In our previous
study, the expression of chondrogenic genes was not
observed in cells cultured in monolayer (Bosnakovski et
al. 2004). However, with the improvement in the sensi-
tivity of RT-PCR techniques, a basal level of gene
expression of collagen type II and aggrecan was detected
in MSCs cultured in medium containing FBS. A low level
of gene expression of collagen type II has also been
detected in untreated human and equine MSCs (Majumdar
et al. 2000; Fortier et al. 1998; Worster et al. 2000a,
2000b). Moreover, murine bone marrow stromal cells
express several markers that are characteristic of osteo-
blastic, chondrogenic, and adipogenic phenotypes at some
point during the extended culture period; this suggests that
individual stromal cells are inherently flexible with respect
to phenotype and demonstrate the potential for plasticity
(Satomura et al. 2000). The effect of TGF-β1 on
chondrocyte proliferation and the synthesis of extracellular
matrix is contextual and may be stimulatory or inhibitory,
depending on the stage of cellular differentiation, growth
condition, and other factors (Glansbeek et al. 1993).
In addition to the promotion of chondrogenesis,
TGF-β1 also stimulates the proliferation of bovine
MSCs in monolayer culture. This is evident even at a
low concentration (1 ng/ml) after 3 days of stimulation.
These results can be correlated with previously published
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reports on the stimulating effect of TGF-β1 on chondro-
cytes and rat MSC proliferation (Qi and Scully 1998;
Andrades et al. 1999); however, they are not in agreement
with studies in which human MSCs have been used
(Walsh at al. 2003). This could be attributable to species
difference, the use of different doses of TGF-β1, or
differences in culture conditions.
Adipogenic differentiation was induced by using a
combination of MIX and dexamethasone, a routinely used
method to stimulate the differentiation of pre-adipocytes
and stem cells. The mechanism of action of both
stimulants is not completely understood; however, certain
studies indicate that the effect is based on the mediation of
cAMP metabolism (Gregoire et al. 1998). In our system,
differentiation was apparent by the accumulation of lipid
vacuoles within cells that developed, coalesced, and
eventually filled the entire cell over a period of time.
Increased expression of aP2 and PPAR-γ2 was detected in
these cells. PPAR-γ2 is an adipocyte-specific gene
belonging to the PPARs family, and together with C/
EBP, is one of the transcription factors that are induced
early during the differentiation of adipocytes (Rosen et al.
1999). AP2 is also an adipose-tissue-specific gene and is
synthesized in the terminal phase of differentiation
(Gregoire et al. 1998). In addition, we have confirmed
an increased expression of lipoprotein lipase in treated
cells (data not shown); however, this marker is not
adipose-tissue-specific and is also synthesized by macro-
phages and other cells of mesenchymal origin (Tengku-
Muhammad et al. 1996). During the screening of adipo-
genesis, aP2 expression has been detected in uncommitted
cells. This may be attributable to the minor contamination
of cell cultures with pre-adipocytes and adipocytes or to
spontaneous adipogenesis in cells in a state of growth
arrest or may be characteristic of the cells of the species.
The method of isolation of MSCs used in this study results
in a cell culture composed of a heterogenic cell population.
Cell clones from this type of culture are reported to grow
into colonies with a wide range of sizes and morphologies
at various proliferation rates and exhibit a potential for
multilineage differentiation. Cells that spontaneously dif-
ferentiate into osteocytes, adipocytes, or chondrocytes
have also been detected in some colonies (Bianco et al.
2001).
A limitation of the present study is the use of an in vitro
model that contains a heterogeneous population of cells.
However, this well-documented system has been pre-
viously used for the confirmation of the presence of MSCs
in cultures of bone marrow stromal cells from various
species by inducing multilineage differentiation at the
single cell level.
In conclusion, we have demonstrated that bovine MSCs,
similar to corresponding cells from other species, exhibit
high proliferation rates and multilineage differentiation
potential. In addition, they can be easily harvested and
isolated, thereby making them attractive tools for further
studies into development and physiology and for clinical
application.
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